These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Valproic acid triggers differentiation and apoptosis in AML1/ETO-positive leukemic cells specifically. Zapotocky M; Mejstrikova E; Smetana K; Stary J; Trka J; Starkova J Cancer Lett; 2012 Jun; 319(2):144-153. PubMed ID: 22261333 [TBL] [Abstract][Full Text] [Related]
11. Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia - identification of responders by gene expression profiling of pretreatment leukemic cells. Reikvam H; Hovland R; Forthun RB; Erdal S; Gjertsen BT; Fredly H; Bruserud Ø BMC Cancer; 2017 Sep; 17(1):630. PubMed ID: 28877686 [TBL] [Abstract][Full Text] [Related]
12. Molecular dissection of valproic acid effects in acute myeloid leukemia identifies predictive networks. Rücker FG; Lang KM; Fütterer M; Komarica V; Schmid M; Döhner H; Schlenk RF; Döhner K; Knudsen S; Bullinger L Epigenetics; 2016 Jul; 11(7):517-25. PubMed ID: 27309669 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA HOTAIR regulates myeloid differentiation through the upregulation of p21 via miR-17-5p in acute myeloid leukaemia. Hu L; Liu J; Meng Y; Zheng H; Ding C; Wang H; Charwudzi A; Li M; Li J; Zhai Z; Xiong S RNA Biol; 2021 Oct; 18(10):1434-1444. PubMed ID: 33241756 [TBL] [Abstract][Full Text] [Related]
14. Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia. Boutzen H; Saland E; Larrue C; de Toni F; Gales L; Castelli FA; Cathebas M; Zaghdoudi S; Stuani L; Kaoma T; Riscal R; Yang G; Hirsch P; David M; De Mas-Mansat V; Delabesse E; Vallar L; Delhommeau F; Jouanin I; Ouerfelli O; Le Cam L; Linares LK; Junot C; Portais JC; Vergez F; Récher C; Sarry JE J Exp Med; 2016 Apr; 213(4):483-97. PubMed ID: 26951332 [TBL] [Abstract][Full Text] [Related]